Tarsus Pharmaceuticals (TARS) Amortization of Intangibles (2023 - 2026)
Tarsus Pharmaceuticals' Amortization of Intangibles came in at $200,000 for Q3 2026, unchanged from $200,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Amortization of Intangibles (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Tarsus Pharmaceuticals reported Amortization of Intangibles of $920,000, up 4.5% year-over-year; for FY2025, it came in at $1 million, up 85.2% from FY2024.
- Going back by year, Amortization of Intangibles was $540,000 in FY2024 (+306.0%) and $133,000 in FY2023.
- The five-year range for quarterly Amortization of Intangibles is $100,000 (Q4 2023) to $280,000 (Q4 2025).
- Year-over-year, Amortization of Intangibles increased in five of the last eight quarters, with growth averaging 62.1%.
- Over the past five years, the year-over-year growth in Amortization of Intangibles ranged from 0.0% (Q1 2026) to 140.0% (Q1 2025).
- Business Quant data shows TARS's Amortization of Intangibles at $200,000 (Q2 2026), $240,000 (Q1 2026) and $280,000 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.70 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.06 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 608.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn | 200,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 200,000.00 |
| Jun 30, 2026 | 200,000.00 |
| Mar 31, 2026 | 240,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 240,000.00 |
| Dec 31, 2024 | 240,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
API Access
Tarsus Pharmaceuticals Amortization of Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortizatization-of-intangibles", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortizatization-of-intangibles&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();